GLP-1 agonists for obesity and type 2 diabetes in children: Systematic review and meta-analysis
{{output}}
Pharmacological options for management of obesity and type 2 diabetes mellitus (T2DM) in children are limited. We aimed to synthesize published randomized controlled trial (RCT) evidence on the efficacy of glucagon-like peptide-1 (GLP-1) agonists in T2DM, pre-... ...
